Clinical Trial Update: XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating XELOX plus cetuximab as first-line therapy for metastatic colorectal cancer; status of the study is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Cetuximab (cetuximab)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Grupo de Investigacao do Cancro Digestivo | Conditions: Colorectal Carcinoma | Phase 2 | Status: UNKNOWN